Wallace, E, Fogo, AB, Schulman, G. Imatinib Therapy for Non-Infection-Related Type II Cryoglobulinemia With Membranoproliferative Glomerulonephritis. Am J Kidney Dis, 59(1), 122-5, 2012
Fogo, AB. The targeted podocyte. J Clin Invest, 121(6), 2142-5, 2011
Zuo, Y, Yang, HC, Potthoff, SA, Najafian, B, Kon, V, Ma, LJ, Fogo, AB. Protective effects of PPAR{gamma} agonist in acute nephrotic syndrome. Nephrol Dial Transplant, 2011
Yamamoto, S, Yancey, PG, Zuo, Y, Ma, LJ, Kaseda, R, Fogo, AB, Ichikawa, I, Linton, MF, Fazio, S, Kon, V. Macrophage Polarization by Angiotensin II-Type 1 Receptor Aggravates Renal Injury-Acceleration of Atherosclerosis. Arterioscler Thromb Vasc Biol, 31(12), 2856-64, 2011
Ma, J, Matsusaka, T, Yang, HC, Zhong, J, Takagi, N, Fogo, AB, Kon, V, Ichikawa, I. Induction of podocyte-derived VEGF ameliorates podocyte injury and subsequent abnormal glomerular development caused by puromycin aminonucleoside. Pediatr Res, 70(1), 83-9, 2011
Scruggs, BS, Zuo, Y, Donnert, E, Ma, L, Bertram, JF, Fogo, AB. Increased capillary branching contributes to angiotensin type 1 receptor blocker (ARB)-induced regression of sclerosis. Am J Pathol, 178(4), 1891-8, 2011
Ma, LJ, Corsa, BA, Zhou, J, Yang, H, Li, H, Tang, YW, Babaev, VR, Major, AS, Linton, MF, Fazio, S, Hunley, TE, Kon, V, Fogo, AB. Angiotensin type 1 receptor modulates macrophage polarization and renal injury in obesity. Am J Physiol Renal Physiol, 300(5), F1203-13, 2011
Yamamoto, S, Zuo, Y, Ma, J, Yancey, PG, Hunley, TE, Motojima, M, Fogo, AB, Linton, MF, Fazio, S, Ichikawa, I, Kon, V. Oral activated charcoal adsorbent (AST-120) ameliorates extent and instability of atherosclerosis accelerated by kidney disease in apolipoprotein E-deficient mice. Nephrol Dial Transplant, 26(8), 2491-7, 2011
Basford, AW, Lewis, J, Dwyer, JP, Fogo, AB. Membranous nephropathy with crescents. J Am Soc Nephrol, 22(10), 1804-8, 2011
Fogo, AB. PPARI? and chronic kidney disease. Pediatr Nephrol, 26(3), 347-51, 2011
Yang, HC, Rossini, M, Ma, LJ, Zuo, Y, Ma, J, Fogo, AB. Cells derived from young bone marrow alleviate renal aging. J Am Soc Nephrol, 22(11), 2028-36, 2011
Yang, HC, Zuo, Y, Fogo, AB. Models of chronic kidney disease. Drug Discov Today Dis Models, 7(1-2), 13-19, 2010
Yang, H, Fogo, AB. Cell senescence in the aging kidney. J Am Soc Nephrol, 21(9), 1436-9, 2010
Naito, T, Ma, LJ, Yang, H, Zuo, Y, Tang, Y, Han, JY, Kon, V, Fogo, AB. Angiotensin type 2 receptor actions contribute to angiotensin type 1 receptor blocker effects on kidney fibrosis. Am J Physiol Renal Physiol, 298(3), F683-91, 2010
Rossini, M, Naito, T, Yang, H, Freeman, M, Donnert, E, Ma, LJ, Dunn, SR, Sharma, K, Fogo, AB. Sulodexide ameliorates early but not late kidney disease in models of radiation nephropathy and diabetic nephropathy. Nephrol Dial Transplant, 25(6), 1803-10, 2010
Matsusaka, T, Asano, T, Niimura, F, Kinomura, M, Shimizu, A, Shintani, A, Pastan, I, Fogo, AB, Ichikawa, I. Angiotensin receptor blocker protection against podocyte-induced sclerosis is podocyte angiotensin II type 1 receptor-independent. Hypertension, 55(4), 967-73, 2010
Pedchenko, V, Bondar, O, Fogo, AB, Vanacore, R, Voziyan, P, Kitching, AR, Wieslander, J, Kashtan, C, Borza, DB, Neilson, EG, Wilson, CB, Hudson, BG. Molecular architecture of the Goodpasture autoantigen in anti-GBM nephritis. N Engl J Med, 363(4), 343-54, 2010
Fogo, AB, Kon, V. The glomerulus--a view from the inside--the endothelial cell. Int J Biochem Cell Biol, 42(9), 1388-97, 2010
He, W, Wang, Y, Zhang, MZ, You, L, Davis, LS, Fan, H, Yang, HC, Fogo, AB, Zent, R, Harris, RC, Breyer, MD, Hao, CM. Sirt1 activation protects the mouse renal medulla from oxidative injury. J Clin Invest, 120(4), 1056-68, 2010
Fogo, AB, Bostad, L, Svarstad, E, Cook, WJ, Moll, S, Barbey, F, Geldenhuys, L, West, M, Ferluga, D, Vujkovac, B, Howie, AJ, Burns, A, Reeve, R, Waldek, S, No?
Breyer, MD, Tchekneva, E, Qi, Z, Takahashi, T, Fogo, AB, Zhao, HJ, Harris, RC. Genetics of diabetic nephropathy: lessons from mice. Semin Nephrol, 27(2), 237-47, 2007
Kanjanabuch, T, Ma, LJ, Chen, J, Pozzi, A, Guan, Y, Mundel, P, Fogo, AB. PPAR-gamma agonist protects podocytes from injury. Kidney Int, 2007
Dwyer, JP, Yates, KM, Sumner, EL, Stone, WJ, Wang, Y, Koury, MJ, Fogo, AB, Zent, R. Chronic myeloid leukemia-associated membranoproliferative glomerulonephritis
that responded to imatinib mesylate therapy. Clin Nephrol, 67(3), 176-81, 2007
Tchekneva, EE, Rinchik, EM, Polosukhina, D, Davis, LS, Kadkina, V, Mohamed, Y, Dunn, SR, Sharma, K, Qi, Z, Fogo, AB, Breyer, MD. A sensitized screen of N-ethyl-N-nitrosourea-mutagenized mice identifies dominant
mutants predisposed to diabetic nephropathy. J Am Soc Nephrol, 18(1), 103-12, 2007
Suganuma, E, Zuo, Y, Ayabe, N, Ma, J, Babaev, VR, Linton, MF, Fazio, S, Ichikawa, I, Fogo, AB, Kon, V. Antiatherogenic effects of angiotensin receptor antagonism in mild renal dysfunction. J Am Soc Nephrol, 17(2), 433-41, 2006
Liang, X, Kanjanabuch, T, Mao, SL, Hao, CM, Tang, YW, Declerck, PJ, Hasty, AH, Wasserman, DH, Fogo, AB, Ma, LJ. Plasminogen activator inhibitor-1 modulates adipocyte differentiation. Am J Physiol Endocrinol Metab, 290(1), E103-E113, 2006
Ayabe, N, Babaev, VR, Tang, Y, Tanizawa, T, Fogo, AB, Linton, MF, Ichikawa, I, Fazio, S, Kon, V. Transiently heightened angiotensin II has distinct effects on atherosclerosis
and aneurysm formation in hyperlipidemic mice. Atherosclerosis, 184(2), 312-21, 2006
Zhao, HJ, Wang, S, Cheng, H, Zhang, MZ, Takahashi, T, Fogo, AB, Breyer, MD, Harris, RC. Endothelial nitric oxide synthase deficiency produces accelerated nephropathy
in diabetic mice. J Am Soc Nephrol, 17(10), 2664-9, 2006
Fogo, AB. Can glomerulosclerosis be reversed. Nat Clin Pract Nephrol, 2(6), 290-1, 2006
Fogo, AB. The clot thickens. Kidney Int, 70(4), 620-1, 2006
Schaefer, HM, Helderman, JH, Fogo, AB. Slow decline in allograft function in a renal transplant patient. Am J Kidney Dis, 48(2), 335-8, 2006
Liang, XB, Ma, LJ, Naito, T, Wang, Y, Madaio, M, Zent, R, Pozzi, A, Fogo, AB. Angiotensin type 1 receptor blocker restores podocyte potential to promote
glomerular endothelial cell growth. J Am Soc Nephrol, 17(7), 1886-95, 2006
Yang, HC, Ma, LJ, Ma, J, Fogo, AB. Peroxisome proliferator-activated receptor-gamma agonist is protective in podocyte
injury-associated sclerosis. Kidney Int, 69(10), 1756-64, 2006
Ma, J, Weisberg, A, Griffin, JP, Vaughan, DE, Fogo, AB, Brown, NJ. Plasminogen activator inhibitor-1 deficiency protects against aldosterone-induced
glomerular injury. Kidney Int, 69(6), 1064-72, 2006
Zuo, Y, Matsusaka, T, Zhong, J, Ma, J, Ma, LJ, Hanna, Z, Jolicoeur, P, Fogo, AB, Ichikawa, I. HIV-1 genes vpr and nef synergistically damage podocytes, leading to glomerulosclerosis. J Am Soc Nephrol, 17(10), 2832-43, 2006
Wang, XP, Fogo, AB, Colon, S, Giannico, G, Abul-Ezz, SR, Miner, JH, Borza, DB. Distinct epitopes for anti-glomerular basement membrane alport alloantibodies
and goodpasture autoantibodies within the noncollagenous domain of alpha3(IV) collagen: a janus-faced
antigen. J Am Soc Nephrol, 16(12), 3563-71, 2005
Revelo, MP, Federspiel, C, Helderman, H, Fogo, AB. Chronic allograft nephropathy: expression and localization of PAI-1 and PPAR-gamma. Nephrol Dial Transplant, 20(12), 2812-9, 2005
Aldigier, JC, Kanjanbuch, T, Ma, LJ, Brown, NJ, Fogo, AB. Regression of existing glomerulosclerosis by inhibition of aldosterone. J Am Soc Nephrol, 16(11), 3306-14, 2005
G??kden, N, Rossini, M, Kumar, J, Fogo, AB. Membranoproliferative injury pattern in a renal allograft. Am J Kidney Dis, 46(3), 573-6, 2005
Zhong, J, Zuo, Y, Ma, J, Fogo, AB, Jolicoeur, P, Ichikawa, I, Matsusaka, T. Expression of HIV-1 genes in podocytes alone can lead to the full spectrum
of HIV-1-associated nephropathy. Kidney Int, 68(3), 1048-60, 2005
Qi, Z, Fujita, H, Jin, J, Davis, LS, Wang, Y, Fogo, AB, Breyer, MD. Characterization of susceptibility of inbred mouse strains to diabetic nephropathy. Diabetes, 54(9), 2628-37, 2005
Xu, BJ, Shyr, Y, Liang, X, Ma, LJ, Donnert, EM, Roberts, JD, Zhang, X, Kon, V, Brown, NJ, Caprioli, RM, Fogo, AB. Proteomic patterns and prediction of glomerulosclerosis and its mechanisms. J Am Soc Nephrol, 16(10), 2967-75, 2005
Fogo, AB. New capillary growth: a contributor to regression of sclerosis. Curr Opin Nephrol Hypertens, 14(3), 201-3, 2005
Matsusaka, T, Xin, J, Niwa, S, Kobayashi, K, Akatsuka, A, Hashizume, H, Wang, QC, Pastan, I, Fogo, AB, Ichikawa, I. Genetic engineering of glomerular sclerosis in the mouse via control of onset
and severity of podocyte-specific injury. J Am Soc Nephrol, 16(4), 1013-23, 2005
Basi, S, Schulman, G, Fogo, AB. Multiple complications in multiple myeloma. Am J Kidney Dis, 45(3), 619-23, 2005
Ma, LJ, Nakamura, S, Aldigier, JC, Rossini, M, Yang, H, Liang, X, Nakamura, I, Marcantoni, C, Fogo, AB. Regression of glomerulosclerosis with high-dose angiotensin inhibition is linked
to decreased plasminogen activator inhibitor-1. J Am Soc Nephrol, 16(4), 966-76, 2005
Weisberg, AD, Albornoz, F, Griffin, JP, Crandall, DL, Elokdah, H, Fogo, AB, Vaughan, DE, Brown, NJ. Pharmacological inhibition and genetic deficiency of plasminogen activator
inhibitor-1 attenuates angiotensin II/salt-induced aortic remodeling. Arterioscler Thromb Vasc Biol, 25(2), 365-71, 2005
Rossini, M, Cheunsuchon, B, Donnert, E, Ma, LJ, Thomas, JW, Neilson, EG, Fogo, AB. Immunolocalization of fibroblast growth factor-1 (FGF-1), its receptor (FGFR-1),
and fibroblast-specific protein-1 (FSP-1) in inflammatory renal disease. Kidney Int, 68(6), 2621-8, 2005
Rossini, M, Coventry, S, Duff, DR, Fogo, AB. Chronic renal failure and abnormal tubular cells in 2 siblings. Am J Kidney Dis, 46(5), 982-7, 2005
Hunley, TE, Corzo, D, Dudek, M, Kishnani, P, Amalfitano, A, Chen, YT, Richards, SM, Phillips, JA, Fogo, AB, Tiller, GE. Nephrotic syndrome complicating alpha-glucosidase replacement therapy for Pompe
disease. Pediatrics, 114(4), e532-5, 2004
Wang, Y, Fogo, AB. Quiz page. Anti-GBM antibody-mediated glomerulonephritis with superimposed
ANCA-associated vasculitis. Am J Kidney Dis, 44(3), A45, e31-2, 2004
Chen, X, Moeckel, G, Morrow, JD, Cosgrove, D, Harris, RC, Fogo, AB, Zent, R, Pozzi, A. Lack of integrin alpha1beta1 leads to severe glomerulosclerosis after glomerular
injury. Am J Pathol, 165(2), 617-30, 2004
Fogo, AB, Rossini, M, Lazin, A. Quiz page. Light chain cast nephropathy. Am J Kidney Dis, 44(1), A45, e1-2, 2004
Ma, Li-Jun, Mao, Su-Li, Taylor, Kevin L, Kanjanabuch, Talerngsak, Guan, YouFei, Zhang, YaHua, Brown, Nancy J, Swift, Larry L, McGuinness, Owen P, Wasserman, David H, Vaughan, Douglas E, Fogo, Agnes B. Prevention of obesity and insulin resistance in mice lacking plasminogen activator inhibitor 1. Diabetes, 53(2), 336-46, 2004
Milstone, A, Vilchez, RA, Geiger, X, Fogo, AB, Butel, JS, Dummer, S. Polyomavirus simian virus 40 infection associated with nephropathy in a lung-transplant
recipient. Transplantation, 77(7), 1019-24, 2004
Wang, Y, Rossini, M, Fogo, AB. Quiz page. HIV-associated nephropathy is the overwhelmingly most likely diagnosis. Am J Kidney Dis, 43(4), A47, e1, 2004
Ma, Li-Jun, Jha, Sharda, Ling, Hong, Pozzi, Ambra, Ledbetter, Steve, Fogo, Agnes B. Divergent effects of low versus high dose anti-TGF-beta antibody in puromycin aminonucleoside nephropathy in rats. Kidney Int, 65(1), 106-15, 2004
Qi, Zhonghua, Whitt, Irene, Mehta, Amit, Jin, Jianping, Zhao, Min, Harris, Raymond C, Fogo, Agnes B, Breyer, Matthew D. Serial determination of glomerular filtration rate in conscious mice using FITC-inulin clearance. Am J Physiol Renal Physiol, 286(3), F590-6, 2004
Good, KS, O''Brien, K, Schulman, G, Kerjaschki, D, Fogo, AB. Unexplained nephrotic-range proteinuria in a 38-year-old man: a case of "no
change disease". Am J Kidney Dis, 43(5), 933-8, 2004
Fogo, Agnes B, . Renal fibrosis: not just PAI-1 in the sky.. J Clin Invest, 112, 326-8, 2003
Fogo, Agnes B, . Editorial Review: The potential for regression of renal scarring.. Curr Opin Nephrol Hypertens, 12, 223-5, 2003
Chang, Ingrid J, Cheunsuchon, Boonyarit, Miller, Frank J, Fogo, Agnes B. A 66-year-old woman with progressive renal insufficiency, nephrotic syndrome, and monoclonal protein. Am J Kidney Dis, 41(2), 508-17, 2003
Fogo, Agnes B, Rossini, Michele. Monoclonal immunoglobin deposition disease, heavy chain deposition type. Am J Kidney Dis, 42(6), A48, E1-2, 2003
Moeckel, Gilbert W, Zhang, Li, Fogo, Agnes B, Hao, Chuan-Ming, Pozzi, Ambra, Breyer, Matthew D. COX2 activity promotes organic osmolyte accumulation and adaptation of renal medullary interstitial cells to hypertonic stress. J Biol Chem, 278(21), 19352-7, 2003
Fogo, Agnes B. Quiz page. Proliferative glomerulonephritis. Am J Kidney Dis, 41(3), xlvii, 2003
Fogo, Agnes B. Quiz page. Acute interstitial nephritis and minimal change disease lesion, caused by NSAID injury. Am J Kidney Dis, 42(2), A41, E1, 2003
Fogo, Agnes B, . Hypertensive risk factors in kidney disease in African Americans.. Kidney Int Suppl, S17-21, 2003
Ma, Li-Jun, Fogo, Agnes B, . Model of robust induction of glomerulosclerosis in mice: importance of genetic background.. Kidney Int, 64, 350-5, 2003
Fogo, Agnes B. Quiz page. Diabetic nephropathy with superimposed acute interstitial nephritis. Am J Kidney Dis, 41(6), A47, E1-3, 2003
Fogo, Agnes B, . Animal models of FSGS: Lessons for pathogenesis and treatment.. Semin Nephrol, 23, 161-71, 2003
Paueksakon, Paisit, Revelo, Monica P, Horn, Robert G, Shappell, Scott, Fogo, Agnes B, . Monoclonal gammopathy: Significance and possible causality in renal disease.. Am J Kidney Dis, 42, 87-95, 2003
Fogo, Agnes B. Approach to renal biopsy. Am J Kidney Dis, 42(4), 826-36, 2003
Ma, Li-Jun, Yang, Haichun, Gaspert, Ariana, Carlesso, Gianluca, Barty, Melissa M, Davidson, Jeffrey M, Sheppard, Dean, Fogo, Agnes B. Transforming growth factor-beta-dependent and -independent pathways of induction of tubulointerstitial fibrosis in beta6(-/-) mice. Am J Pathol, 163(4), 1261-73, 2003
Nishida M, Fujinaka H, Matsusaka T, Price J, Kon V, Fogo AB, Davidson JM, Linton MF, Fazio S, Homma T, Yoshida H, Ichikawa I. . IAbsence of angiotensin II type 1 receptor in bone marrow-derived cells is detrimental in the evolution of renal fibrosis. . J Clin Invest , 110, 1859-1868, 2002
Kaikita, Koichi, Schoenhard, John A, Painter, Corrie A, Ripley, Robert T, Brown, Nancy J, Fogo, Agnes B, Vaughan, Douglas E. Potential roles of plasminogen activator system in coronary vascular remodeling induced by long-term nitric oxide synthase inhibition. J Mol Cell Cardiol, 34(6), 617-27, 2002
Moeckel, Gilbert W, Jabs, Kathy, Fogo, Agnes B. An 11-year-old African-American girl with systemic lupus erythematosus and ANCA-negative renal vasculitis. Am J Kidney Dis, 39(2), 433-8, 2002
Fogo, A B. Mechanisms in nephrosclerosis and hypertension-beyond hemodynamics. J Nephrol, 14 Suppl 4, S63-9, 2002
Nishida, Masashi, Fujinaka, Hidehiko, Matsusaka, Taiji, Price, James, Kon, Valentina, Fogo, Agnes B, Davidson, Jeffrey M, Linton, MacRae F, Fazio, Sergio, Homma, Toshio, Yoshida, Hiroaki, Ichikawa, Iekuni. Absence of angiotensin II type 1 receptor in bone marrow-derived cells is detrimental in the evolution of renal fibrosis. J Clin Invest, 110(12), 1859-68, 2002
Fogo, Agnes B. Quiz page. Mesangial lupus nephritis, WHO IIb, and severe acute tubular necrosis, secondary to gentamycin toxicity. Am J Kidney Dis, 40(5), xlix, 2002
Brown, Nancy J, Vaughan, Douglas E, Fogo, Agnes B. The renin-angiotensin-aldosterone system and fibrinolysis in progressive renal disease. Semin Nephrol, 22(5), 399-406, 2002
Fogo, Agnes B. Quiz page. Transplant glomerulopathy. Am J Kidney Dis, 40(3), xli, 2002
Fogo, Agnes B. Quiz page. Diabetic nephropathy and extensive, superimposed, intratubular, calcium oxalate crystals, due to enteric hyperoxaluria. Am J Kidney Dis, 40(2), xl, 2002
Fogo, Agnes B. Quiz page. Light chain cast nephropathy with light chain deposition disease. Am J Kidney Dis, 39(6), xlii, 2002
Fogo, Agnes B. Quiz page. Fibrillary glomerulonephritis. Am J Kidney Dis, 39(5), liii, 2002
Paueksakon, Paisit, Revelo, Monica P, Ma, Li-Jun, Marcantoni, Carmelita, Fogo, Agnes B. Microangiopathic injury and augmented PAI-1 in human diabetic nephropathy. Kidney Int, 61(6), 2142-8, 2002
Fogo, Agnes B. Quiz page. AA amyloidosis. Am J Kidney Dis, 39(3), 444, 2002
Fogo, Agnes B. Quiz page. IgA nephropathy. Am J Kidney Dis, 39(2), xlviii, 2002
Brown, Nancy J, Vaughan, Douglas E, Fogo, Agnes B. Aldosterone and PAI-1: implications for renal injury. J Nephrol, 15(3), 230-5, 2002
Paueksakon P, Revelo MP, Ma L-j, Marcantoni C, Fogo AB.. Microangiopathic injury and augmented PAI-1 in human diabetic nephropathy. . Kidney Int , 61, 2142-2148, 2002
Fogo A. Progression and potential regression of
glomerulosclerosis.
Nephrology Forum. Kidney Int, 59, 804-819, 2001
Fogo, A B. Renal fibrosis and the renin-angiotensin system. Adv Nephrol Necker Hosp, 31, 69-87, 2001
Fogo, A B. Minimal change disease and focal segmental glomerulosclerosis. Nephrol Dial Transplant, 16 Suppl 6, 74-6, 2001
Ma, L, Fogo, A B. Role of angiotensin II in glomerular injury. Semin Nephrol, 21(6), 544-53, 2001
Fogo, A B. Progression and potential regression of glomerulosclerosis. Kidney Int, 59(2), 804-19, 2001
Ma, L J, Fogo, A B. Angiotensin as inducer of plasminogen activator inhibitor-1 and fibrosis. Contrib Nephrol(135), 161-70, 2001
Kaikita, K, Fogo, A B, Ma, L, Schoenhard, J A, Brown, N J, Vaughan, D E. Plasminogen activator inhibitor-1 deficiency prevents hypertension and vascular fibrosis in response to long-term nitric oxide synthase inhibition. Circulation, 104(7), 839-44, 2001
Ma, L J, Marcantoni, C, Linton, M F, Fazio, S, Fogo, A B. Peroxisome proliferator-activated receptor-gamma agonist troglitazone protects against nondiabetic glomerulosclerosis in rats. Kidney Int, 59(5), 1899-910, 2001
Revelo, M P, Staffeld, C, Copley, J B, Fogo, A B. A 26-year-old man with kidney allograft failure and foot pain. Am J Kidney Dis, 37(4), 871-5, 2001
Langone, A J, Revelo, M P, Schulman, G, Fogo, A B. A young man with 20 years of nephrotic range proteinuria without loss of renal function. Am J Kidney Dis, 38(6), 1329-33, 2001
Brown NJ, Nakamura S, Ma L-J, Nakamura I, Donnert E,
Freeman M, Vaughan
DE, Fogo AB. Aldosterone modulates plasminogen
activator inhibitor-1
and
glomerulosclerosis in vivo. Kidney Int , 58, 1219-1227, 2000
Fogo, A B. The role of angiotensin II and plasminogen activator inhibitor-1 in progressive glomerulosclerosis. Am J Kidney Dis, 35(2), 179-88, 2000
Fogo AB. The role of angiotensin II and plasminogen
activator inhibitor-
1 in progressive glomerulosclerosis. Am J Kidney Dis , 35, 179-188, 2000
Miyazaki Y, Oshima K, Fogo A, Hogan BL, Ichikawa I. Bone morphogenetic protein 4 regulates the budding
site and elongation of the mouse urete. J Clin Invest, 105, 863-873, 2000
Matsusaka T, Kon V, Takaya J, Katori H, Chen Xm, Miyazaki Ji, Homma T, Fogo A, Ichikawa I. : Dual renin gene
targeting by Cre-mediated interchromosomal recombination. Genomics, 64, 127-131, 2000
Nakamura S, Nakamura I, Ma LJ, Vaughan DE, Fogo AB. Plasminogen activator inhibitor-1 expression is
regulated by the angiotensin type 1 receptor in vivo. Kidney Int, 58, 251-259, 2000
Hoyer JR, Fogo AB, Terrell CH, Delaney MM. Immunomorphometric studies of proteinuria in individual deep
and superficial nephrons of rats. Lab Invest, 80, 1691-1700, 2000
Fujinaka H, Miyazaki Y, Matsusaka T, Yoshida H, Fogo AB, Inagami T, Ichikawa I. Salutary role for angiotensin
in partial urinary tract obstruction. Kidney Int, 58, 2018-2027, 2000
Brown, N J, Nakamura, S, Ma, L, Nakamura, I, Donnert, E, Freeman, M, Vaughan, D E, Fogo, A B. Aldosterone modulates plasminogen activator inhibitor-1 and glomerulosclerosis in vivo. Kidney Int, 58(3), 1219-27, 2000
Paueksakon, P, Revelo, M, Lee, S M, Horn, R G, Fogo, A B. Acute renal failure in a 64-year-old white man. Am J Kidney Dis, 36(3), 669-74, 2000
Ma, L J, Nakamura, S, Whitsitt, J S, Marcantoni, C, Davidson, J M, Fogo, A B. Regression of sclerosis in aging by an angiotensin inhibition-induced decrease in PAI-1. Kidney Int, 58(6), 2425-36, 2000
Nakamura, S, Nakamura, I, Ma, L, Vaughan, D E, Fogo, A B. Plasminogen activator inhibitor-1 expression is regulated by the angiotensin type 1 receptor in vivo. Kidney Int, 58(1), 251-9, 2000
Fogo, A B. Pathology of progressive nephropathies. Curr Opin Nephrol Hypertens, 9(3), 241-6, 2000
Revelo, M P, Pauesakon, P, Weidner, M, Helderman, J H, Horn, R G, Fogo, A B. A 37-year-old woman with systemic lupus erythematosus and acute allograft failure. Am J Kidney Dis, 35(6), 1242-7, 2000
Fogo, A B. Glomerular hypertension, abnormal glomerular growth, and progression of renal diseases. Kidney Int Suppl, 75, S15-21, 2000
Fujinaka, H, Miyazaki, Y, Matsusaka, T, Yoshida, H, Fogo, A B, Inagami, T, Ichikawa, I. Salutary role for angiotensin in partial urinary tract obstruction. Kidney Int, 58(5), 2018-27, 2000
Revelo, M P, Paueksakon, P, Goral, S, Helderman, H, Fogo, A B. A 14-year-old boy with kidney allograft failure in the first month after transplantation. Am J Kidney Dis, 36(4), 871-4, 2000
Fogo, A B. New insights into the renin-angiotensin system and hypertensive renal disease. Curr Hypertens Rep, 1(2), 187-94, 2000
Ma LJ, Nakamura S, Whitsitt JS, Marcantoni C, Davidson JM,
Fogo AB. Regression of sclerosis in aging by an angiotensin inhibition-
induced
decrease in PAI-1. Kidney Int, 58, 2425-2436, 2000
Fogo, A B. Mesangial matrix modulation and glomerulosclerosis. Exp Nephrol, 7(2), 147-59, 1999
Tsuchida S, Miyazaki Y, Matsusaka T, Hunley TE, Inagami T, Fogo A, Ichikawa I. Potent antihypertrophic effect
of the bradykinin B2 receptor system on the renal vasculature. Kidney Int , 56, 509-516, 1999
Fogo, A B. Current concepts in glomerulosclerosis. Am J Kidney Dis, 34(5), liv-lvi, 1999
Paueksakon, P, Hunley, T E, Lee, S M, Fogo, A B. A 12-year-old girl with pulmonary hemorrhage, skin lesions, and hematuria. Am J Kidney Dis, 33(2), 404-9, 1999
Miyazaki Y, Tsuchida S, Fogo A, Ichikawa I. The renal lesions that develop in neonatal mice during angiotensin
inhibition mimic obstructive nephropathy. Kidney Int, 55, 1683-1695, 1999
Matsusaka T, Katori H, Inagami T, Fogo A, Ichikawa I. Communication between myocytes and fibroblasts in
cardiac remodeling in angiotensin chimeric mice. J Clin Invest, 103, 1451-1458, 1999
Miyazaki Y, Tsuchida S, Nishimura H, Pope JC IV, Harris RC, McKanna JM, Inagami T, Hogan BLM, Fogo A,
Ichikawa I. Angiotensin induces the urinary peristaltic machinery during the perinatal period. J Clin Invest, 102, 1489-1497, 1998
Ma J, Nishimura H, Fogo A, Kon V, Inagami T, Ichikawa I. Accelerated fibrosis and collagen deposition develop
in the renal interstitium of angiotensin type 2 receptor null mutant mice during ureteral obstruction. Kidney Int, 53, 937-944, 1998
Okubo S, Niimura F, Matsusaka T, Fogo A, Hogan BLM, Ichikawa I. Angiotensinogen gene null-mutant mice lack
homeostatic regulation of glomerular filtration and tubular reabsorption. Kidney Int, 53, 617-625, 1998
Mrukowicz, J Z, Wetzel, J D, Goral, M I, Fogo, A B, Wright, P F, Dermody, T S. Viruses and cells with mutations affecting viral entry are selected during persistent rotavirus infections of MA104 cells. J Virol, 72(4), 3088-97, 1998
Tsuchida S, Matsusaka T, Chen X, Okubo S, Niimura F, Nishimura H, Fogo A, Utsunomiya H, Inagami T,
Ichikawa I. Murine double nullizygotes of the angiotensin type 1A and type 1B receptor genes duplicate severe
abnormal phenotypes of angiotensinogen nullizygotes. J Clin Invest, 101, 755-760, 1998
Wetzel, J D, Chappell, J D, Fogo, A B, Dermody, T S. Efficiency of viral entry determines the capacity of murine erythroleukemia cells to support persistent infections by mammalian reoviruses. J Virol, 71(1), 299-306, 1997
Fogo A, Breyer JA, Smith MC, Cleveland WH, Agodoa L, Kirk KA, Glassock R. Accuracy of the diagnosis of
hypertensive nephrosclerosis in African Americans- a report from the AASK trial. Kidney Int, 51, 244-252, 1997
Dunn, N R, Winnier, G E, Hargett, L K, Schrick, J J, Fogo, A B, Hogan, B L. Haploinsufficient phenotypes in Bmp4 heterozygous null mice and modification by mutations in Gli3 and Alx4. Dev Biol, 188(2), 235-47, 1997
Niimura F, Okubo S, Fogo A, Ichikawa I. Temporal and spatial expression pattern of the angiotensinogen gene
in mice and rats. Am J Physiol, R142-R147, 272, 1997
Chen X, Li W, Yoshida H, Tsuchida S, Nishimura H, Takemoto F, Okubo S, Fogo A, Matsusaka T, Ichikawa I. Targeting deletion of angiotensin type 1B receptor gene in the mouse. Am J Physiol, 272, F299-F304, 1997
Okubo S, Niimura F, Nishimura H, Takemoto F, Fogo A, Matsusaka T, Ichikawa I. Angiotensin-independent
mechanism for aldosterone synthesis during chronic extracellular fluid volume depletion. J Clin Invest , 855-860, 99, 1997
Oikawa T, Freeman M, Lo W, Vaughan DE, Fogo A. Modulation of plasminogen activator inhibitor-1 (PAI-1) in
vivo: A new mechanism for the anti-fibrotic effect of renin-angiotensin inhibition. Kidney Int, 51, 164-172, 1997
Nishimura H, Matsusaka T, Fogo A, Kon V, Ichikawa I. A novel in vivo mechanism for angiotensin type 1 receptor
regulation. Kidney Int, 52, 345-355, 1997
Hunley TE, Julian BA, Phillips JA, Summar ML, Yoshida H, Horn RG, Brown NJ, Fogo A, Ichikawa I, Kon V. Angiotensin converting enzyme gene polymorphism: Potential silencer motif and impact on progression in IgA
nephropathy. Kidney Int, 571-577, 49, 1996
Suzuki, N, Labosky, P A, Furuta, Y, Hargett, L, Dunn, R, Fogo, A B, Takahara, K, Peters, D M, Greenspan, D S, Hogan, B L. Failure of ventral body wall closure in mouse embryos lacking a procollagen C-proteinase encoded by Bmp1, a mammalian gene related to Drosophila tolloid. Development, 122(11), 3587-95, 1996
Matsusaka T, Nishimura H, Utsunomiya H, Kakuchi J, Niimura F, Inagami T, Fogo A, Ichikawa I. Chimeric mice
carrying "regional" targeted deletion of the angiotensin type 1a receptor gene: Evidence against the role for
local angiotensin in the in vivo feedback regulation of renin synthesis in juxtaglomerular cells. J Clin Invest, 98, 1867-1877, 1996
Ichiki, T., Labosky, P. A., Shiota, C., Okuyama, S., Imagawa,
Y., Fogo,
A., Miimura, F., Ichikawa, I., Hogan, B. L. M., Inagami, T. Effects on blood pressure and exploratory behaviour of mice
lacking
angiotensin II type-2 receptor. Nature, 377, 748-750, 1995
Motojima, M, Nishijima, F, Ikoma, M, Kawamura, T, Yoshioka, T, Fogo, A B, Sakai, T, Ichikawa, I. Role for 'uremic toxin' in the progressive loss of intact nephrons in chronic renal failure. Kidney Int, 40(3), 461-9, 1991
Teague, M W, Glick, A D, Fogo, A B. Adenovirus infection of the kidney: mass formation in a patient with Hodgkin's disease. Am J Kidney Dis, 18(4), 499-502, 1991
Butler, M G, Fogo, A B, Fuchs, D A, Collins, F S, Dev, V G, Phillips, J A. Two patients with ring chromosome 15 syndrome. Am J Med Genet, 29(1), 149-54, 1988
